Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Q3 2023 Earnings Call Transcript November 2, 2023
Alnylam Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $1.15, expectations were $-1.61.
Operator: Good day and thank you for standing by. Welcome to the Alnylam Pharmaceuticals Q3 2023 Earnings Conference Call. At this time, participants are in a listen-only mode. After the speakers’ presentation, there will be a question-and-answer session. Please be advised that today’s...
